Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure
The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study...
| Published in: | Viruses |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/13/4/562 |
